US-based Medtronic has reportedly inked a deal with Ireland-based Covidien, a move that will lead to Medtronic to move its medical device manufacturing operations overseas.
Reports say Medtronic will acquire Covidien for $42.9 billion and move its executive base to Ireland. It’s part of a strategy by the US firm to …read more
Source: Global Competition Law Blogs